Thomas Kergrohen

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

David Castel, Thomas Kergrohen, Arnault Tauziède‐Espariat et al. · Acta Neuropathologica · 2020 · 176 citations

Chromatin, Glioma, Chromatin Remodeling +10

TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)

Coralie Werbrouck, Cláudia C.S. Evangelista, María-Jesús Lobón-Iglesias et al. · Clinical Cancer Research · 2019 · 145 citations

Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location

David Castel, Cathy Philippe, Thomas Kergrohen et al. · Acta Neuropathologica Communications · 2018 · 124 citations · Full text

Both rare and common genetic variants contribute to autism in the Faroe Islands

Claire S. Leblond, Freddy Cliquet, Coralie Carton et al. · npj Genomic Medicine · 2019 · 85 citations · Full text

A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation

Lucie Auffret, Yassine Ajlil, Arnault Tauziède‐Espariat et al. · Acta Neuropathologica · 2023 · 62 citations · Full text